Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Antibiotic Coated Nail to Prevent Infection
NCT05421741Phase 4Recruiting
- Sponsor
- Wake Forest University Health Sciences
- Start
- May 2023
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of vancomycin and gentamicin in surgical site infection (SSI) (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoint: Deep surgical site infection. Started May 2023; status: recruiting.
02
Drugs
vancomycingentamicin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT05421741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05421741.